Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Magali Genevray"'
Autor:
Kirsten Mundt, Benjamin M. Beckermann, Nastya Kassir, Christophe Schmitt, Candice Jamois, Magali Genevray, Claire Petry, Joy Yang, Doreen Anders
Publikováno v:
Blood. 136:7-8
Background: Myelosuppression, and especially severe and prolonged neutropenia, can make patients (pts) with acute myeloid leukemia (AML) susceptible to fatal infections. Idasanutlin (idasa), a MDM2 antagonist promoting p53 tumor suppressor activity,
Autor:
Noppadol Siritanaratkul, Martin Barrett, Andrew Davies, David MacDonald, Artem Zharkov, Mark Dixon, Philippe Solal-Celigny, Santiago Mercadal, Francesco Merli, Biljana Mihaljevic, Michael Brewster, Magali Genevray, Claude Berge, Axel Boehnke
Publikováno v:
The Lancet. Haematology. 4(6)
Summary Background Intravenous rituximab is the standard of care in B-cell non-Hodgkin lymphoma, and is administered over 1·5–6 h. A subcutaneous formulation could reduce patients' treatment burden and improve resource utilisation in health care.
Autor:
Lorenzo Dal Bo, Fabrizio Crivelli, Monia Crivelli, Antonio Marzo, Paolo Mazzucchelli, Thomas G. Keller, Magali Genevray, Nathalie Cambon, Shevqet Ismaili
Publikováno v:
Arzneimittel-Forschung. 55(9)
Fluoxetine hydrochloride (CAS 59333-67-4) is a selective serotonin reuptake inhibitor (SSRI) widely used as antidepressant drug. The aim of the present trial was to assess the bioequivalence of a new formulation of the drug (test formulation) as comp